Evonik has entered into a long-term supply agreement with Phathom Pharmaceuticals, under which Evonik will produce large-scale volumes of vonoprazan at its FDA-inspected manufacturing sites in Tippecanoe, IN, and Dossenheim, Germany.   “The manufacture of vonoprazan requires multi-step syntheses involving complex chemistries. We are delighted to be able to bring the right mix of technologies and assets to this collaboration,” said Thomas Riermeier, head of the Health Care bus...